Physician profile
Alexander Orem
NPI 1811130073
$215,069.67
in general payments reported to CMS, 2019-2025
9 companies · $76K in 2025
The $76K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $118 · 2021: $357 · 2022: $17K · 2023: $37K · 2024: $70K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $163K · Travel and Lodging: $16K · Food and Beverage: $3,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $163,425.00 |
| Travel and Lodging | $16,124.65 |
| Food and Beverage | $3,429.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $211,231.61 | 2019-2025 | Gmk Sphere, Amistem, Quadra |
| Medical Device Business Services, INC. | $3,050.39 | 2024-2025 | Velys, Emphasys, Actis |
| Stryker Corporation | $182.67 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $145.88 | 2025 | |
| Smith+Nephew, INC. | $126.27 | 2022 | |
| Depuy Synthes Sales INC. | $122.26 | 2019 | |
| Think Surgical, INC. | $111.13 | 2024 | |
| Onkos Surgical, INC. | $77.72 | 2022 | |
| Tactile Systems Technology INC | $21.74 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Orem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.